Free tool
Healthcare stocks
We cover 131 companies in the Healthcare sector. The median market value in the group is $3.43B. Across the group, the median move over the past trading day is +0.07%. 89% of the 130 with a 200-day average trade above it. Price change over the past year runs from −36.8% to +203.5% across the middle 80 percent of the group, with a median of +26.1%. Across the group, 2 companies currently carry a tier A volume signal.
Other lists in this group
Table
131 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| MRCK34.SA | Merck & Co., Inc. | $388.60B | Mega cap | +81.07% |
| 6MK.DE | Merck & Co., Inc. | $379.64B | Mega cap | +91.49% |
| MRK | Merck & Co., Inc. | $377.72B | Mega cap | +86.85% |
| AMGN34.SA | Amgen Inc. | $239.09B | Mega cap | +47.79% |
| AMGN | Amgen Inc. | $238.06B | Mega cap | +56.24% |
| AMG.DE | Amgen Inc. | $237.76B | Mega cap | +60.12% |
| TMO | Thermo Fisher Scientific Inc. | $234.31B | Mega cap | +30.17% |
| TMOS34.SA | Thermo Fisher Scientific Inc. | $231.47B | Mega cap | +22.22% |
| PFIZ34.SA | Pfizer Inc. | $161.53B | Large cap | +11.58% |
| BMYB34.SA | Bristol-Myers Squibb Company | $138.65B | Large cap | +40.74% |
| H1CA34.SA | HCA Healthcare, Inc. | $92.89B | Large cap | +2.99% |
| RGO.DE | Regeneron Pharmaceuticals, Inc. | $84.24B | Large cap | −5.91% |
| ARGX | argenx SE | $65.51B | Large cap | +47.90% |
| A1RG34.SA | argenx SE | $63.16B | Large cap | +36.97% |
| CSL.AX | CSL Limited | $59.72B | Large cap | −16.37% |
| 0QF.DE | Moderna, Inc. | $59.07B | Large cap | +550.51% |
| TAKP34.SA | Takeda Pharmaceutical Company Limited | $57.22B | Large cap | +18.03% |
| BOX.DE | Becton, Dickinson and Company | $51.84B | Large cap | +1.73% |
| BDX | Becton, Dickinson and Company | $51.81B | Large cap | +25.97% |
| B1DX34.SA | Becton, Dickinson and Company | $51.78B | Large cap | −113.87% |
| NTRA | Natera, Inc. | $48.53B | Large cap | +107.59% |
| T1EV34.SA | Teva Pharmaceutical Industries Limited | $44.24B | Large cap | +94.70% |
| IQV | IQVIA Holdings Inc. | $43.04B | Large cap | +38.51% |
| QTS.DE | IQVIA Holdings Inc. | $43.01B | Large cap | −4.04% |
| V2EE34.SA | Veeva Systems Inc. | $41.01B | Large cap | −18.65% |
| WATC34.SA | Waters Corporation | $36.35B | Large cap | +24.76% |
| I1LM34.SA | Illumina, Inc. | $34.10B | Large cap | +113.13% |
| ILU.DE | Illumina, Inc. | $34.08B | Large cap | +129.80% |
| ILMN | Illumina, Inc. | $33.95B | Large cap | +125.88% |
| BIIB34.SA | Biogen Inc. | $32.56B | Large cap | +47.86% |
| B1NT34.SA | BioNTech SE | $28.32B | Large cap | +2.68% |
| 22UA.DE | BioNTech SE | $28.28B | Large cap | +14.09% |
| LH | Labcorp Holdings Inc. | $27.39B | Large cap | +21.14% |
| DGX | Quest Diagnostics Incorporated | $26.99B | Large cap | +38.12% |
| I1NC34.SA | Incyte Corporation | $25.83B | Large cap | +41.91% |
| GMAB.CO | Genmab A/S | $20.69B | Large cap | +36.19% |
| GE9.DE | Genmab A/S | $20.65B | Large cap | −11.12% |
| Z1BH34.SA | Zimmer Biomet Holdings, Inc. | $18.07B | Large cap | −5.04% |
| C1OO34.SA | The Cooper Companies, Inc. | $15.12B | Large cap | −0.89% |
| ERF.PA | Eurofins Scientific SE | $14.64B | Large cap | +15.60% |
| CRL | Charles River Laboratories International, Inc. | $14.09B | Large cap | +81.27% |
| B1MR34.SA | BioMarin Pharmaceutical Inc. | $12.54B | Large cap | +4.97% |
| HALO | Halozyme Therapeutics, Inc. | $12.41B | Large cap | +46.30% |
| T1CH34.SA | Bio-Techne Corporation | $11.51B | Large cap | +23.42% |
| U1HS34.SA | Universal Health Services, Inc. | $10.55B | Large cap | −6.44% |
| BIO | Bio-Rad Laboratories, Inc. | $10.40B | Large cap | +32.71% |
| RGEN | Repligen Corporation | $10.25B | Large cap | +51.67% |
| APGE | Apogee Therapeutics, Inc. | $10.21B | Large cap | +257.11% |
| BIO-B | Bio-Rad Laboratories, Inc. | $9.77B | Mid cap | +47.78% |
| CRNX | Crinetics Pharmaceuticals, Inc. | $9.00B | Mid cap | +179.08% |
| TXG | 10x Genomics, Inc. | $8.37B | Mid cap | +358.35% |
| RHC.AX | Ramsay Health Care Limited | $8.27B | Mid cap | +50.11% |
| CAI | Caris Life Sciences, Inc. | $7.58B | Mid cap | −29.83% |
| HLUN-A.CO | H. Lundbeck A/S | $6.40B | Mid cap | +29.71% |
| CNTA | Centessa Pharmaceuticals plc | $6.27B | Mid cap | +143.24% |
| HAE | Haemonetics Corporation | $4.85B | Mid cap | +93.71% |
| HTFL | Heartflow, Inc. | $4.26B | Mid cap | +40.79% |
| ITGR | Integer Holdings Corporation | $4.25B | Mid cap | +15.84% |
| ANN.AX | Ansell Limited | $4.17B | Mid cap | +18.41% |
| AMLX | Amylyx Pharmaceuticals, Inc. | $4.13B | Mid cap | +292.38% |
| IDYA | IDEAYA Biosciences, Inc. | $4.01B | Mid cap | +66.32% |
| ABCL | AbCellera Biologics Inc. | $3.97B | Mid cap | +181.38% |
| CPRX | Catalyst Pharmaceuticals Inc | $3.85B | Mid cap | +55.97% |
| OGN | Organon & Co. | $3.62B | Mid cap | +50.67% |
| A2LC34.SA | Alcon Inc. | $3.57B | Mid cap | −12.15% |
| PLSE | Pulse Biosciences, Inc. | $3.43B | Mid cap | +203.47% |
| MRVI | Maravai LifeSciences Holdings, Inc. | $3.30B | Mid cap | +281.97% |
| AVAH | Aveanna Healthcare Holdings Inc. | $2.97B | Mid cap | +73.50% |
| ZLAB | Zai Lab Limited | $2.92B | Mid cap | −20.06% |
| ATAI | AtaiBeckley Inc. | $2.74B | Mid cap | +61.71% |
| AMBU-B.CO | Ambu A/S | $2.69B | Mid cap | −19.13% |
| CDNA | CareDx, Inc. | $2.64B | Mid cap | +283.45% |
| BV3.DE | Bavarian Nordic A/S | $2.55B | Mid cap | +15.65% |
| RAPP | Rapport Therapeutics, Inc. | $2.52B | Mid cap | +250.70% |
| BAVA.CO | Bavarian Nordic A/S | $2.51B | Mid cap | −7.97% |
| ATRC | AtriCure, Inc. | $2.45B | Mid cap | +29.14% |
| ONT.L | Oxford Nanopore Technologies plc | $2.41B | Mid cap | −2.24% |
| EKTA-B.ST | Elekta AB (publ) | $2.20B | Mid cap | +26.10% |
| XNCR | Xencor, Inc. Common Stock | $2.11B | Mid cap | +254.61% |
| ZYME | Zymeworks Inc. | $2.10B | Mid cap | +96.28% |
| PRGO | Perrigo Company plc | $2.05B | Mid cap | −36.05% |
| DWTX | Dogwood Therapeutics, Inc. | $90.42M | Micro cap | −42.80% |
| 366A.T | WELLNESS COMMUNICATIONS CORPORA | $89.79M | Micro cap | −23.84% |
| SAR.L | Sareum Holdings plc | $70.10M | Micro cap | +76.19% |
| INCR | InterCure Ltd. | $69.65M | Micro cap | +265.03% |
| CINPHA.ST | Cinclus Pharma Holding AB (publ) | $68.21M | Micro cap | −11.27% |
| INMB | INmune Bio Inc. | $67.86M | Micro cap | +19.56% |
| 4512.T | Wakamoto Pharmaceutical Co.,Ltd. | $67.16M | Micro cap | +1.97% |
| 4584.T | Kidswell Bio Corporation | $55.44M | Micro cap | −26.03% |
| PRPO | Precipio, Inc. | $54.43M | Micro cap | +99.25% |
| OHGR.L | One Health Group Plc | $53.82M | Micro cap | +17.03% |
| ENP.AX | Entropy Neurodynamics Limited | $48.13M | Micro cap | +10.81% |
| HOWL | Werewolf Therapeutics, Inc. | $48.05M | Micro cap | −25.65% |
| 4583.T | Chiome Bioscience Inc. | $42.82M | Micro cap | −36.76% |
| HBIO | Harvard Bioscience, Inc. | $34.83M | Micro cap | +44.34% |
| AREC.L | Arecor Therapeutics plc | $33.86M | Micro cap | +3.94% |
| KYNB | Kyntra Bio, Inc. | $32.82M | Micro cap | −22.66% |
| SIGHT.PA | GenSight Biologics S.A. | $32.26M | Micro cap | −25.31% |
| IRLAB-A.ST | IRLAB Therapeutics AB (publ) | $27.48M | Micro cap | −44.31% |
| TXMD | TherapeuticsMD, Inc. | $26.39M | Micro cap | +103.57% |
| RENX.L | Renalytix Plc | $25.24M | Micro cap | −26.50% |
| RUA.L | RUA Life Sciences plc | $24.04M | Micro cap | +130.93% |
| ALTAO.PA | Aton | $22.75M | Micro cap | +153.85% |
| BFRI | Biofrontera Inc. | $22.72M | Micro cap | +77.91% |
| PMI | Picard Medical, Inc. | $20.13M | Micro cap | +113.51% |
| VYNE | VYNE Therapeutics Inc | $19.07M | Micro cap | +8660.74% |
| 5619.T | MRSO INC | $18.85M | Micro cap | −16.43% |
| EZZ.AX | EZZ Life Science Holdings Limited | $18.76M | Micro cap | −77.25% |
| LEXX | Lexaria Bioscience Corp. | $18.24M | Micro cap | +1146.05% |
| BCDA | BioCardia, Inc. | $18.02M | Micro cap | −38.66% |
| 7813.T | Platz Co., Ltd. | $17.74M | Micro cap | +18.51% |
| CMMB | Chemomab Therapeutics Ltd. | $16.85M | Micro cap | −25.57% |
| BTC.AX | BTC Health Limited | $15.67M | Micro cap | −1.61% |
| ICR.AX | Intelicare Holdings Limited | $14.91M | Micro cap | +75.76% |
| GSS.AX | Genetic Signatures Limited | $14.20M | Micro cap | −71.00% |
| ICO.ST | Iconovo AB (publ) | $12.72M | Micro cap | −52.09% |
| CRTX.L | CRISM Therapeutics Corporation | $12.38M | Micro cap | +9.52% |
| APRE | Aprea Therapeutics, Inc. | $12.34M | Micro cap | −38.75% |
| LUCY | Lucyd, Inc | $9.73M | Micro cap | −42.05% |
| FBLG | FibroBiologics, Inc. | $9.39M | Micro cap | −88.25% |
| 7090.T | Ligua Inc. | $9.09M | Micro cap | −15.65% |
| XBIO | Xenetic Biosciences, Inc. | $9.04M | Micro cap | +35.92% |
| SKYE | Skye Bioscience, Inc. | $8.92M | Micro cap | −41.62% |
| CURX | Curanex Pharmaceuticals Inc | $7.21M | Micro cap | −1.29% |
| IXC.AX | Invex Therapeutics Ltd | $7.00M | Micro cap | +30.00% |
| CNSL.L | Cambridge Nutritional Sciences plc | $6.14M | Micro cap | −41.54% |
| GLMD | Galmed Pharmaceuticals Ltd. | $4.48M | Micro cap | +211.51% |
| FDBK.L | Feedback plc | $4.08M | Micro cap | −48.30% |
| BIAF | bioAffinity Technologies, Inc. | $3.02M | Micro cap | −31.59% |
| SCNI | Scinai Immunotherapeutics Ltd. | $1.48M | Micro cap | +93.92% |
| APM | Aptorum Group Ltd | $570.06K | Micro cap | +273.78% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.